• Direct Mouse Genotyping Kit Plus: Mechanistic QC

  2026-09-08

  The Direct Mouse Genotyping Kit Plus can strengthen the genotype-to-phenotype audit trail in macrophage EP4 mouse models. This article connects rapid DNA preparation and high-fidelity PCR with assay decisions for transgene detection, gene knockout validation, and cardiovascular research reproducibility.

• Pexidartinib and the CSF1R Logic of Cell State

  2026-09-08

  Pexidartinib (PLX3397) offers a receptor-directed way to interrogate macrophage and microglial biology. This thought-leadership analysis connects CSF1R-mediated signaling inhibition in oncology with emerging evidence that microglial activation reshapes hippocampal synaptic balance, while defining the experimental safeguards needed for responsible translational interpretation.

• Calcitriol and NFIA: A New Lens on Bone Homeostasis

  2026-09-07

  A translational framework linking Calcitriol biology with NFIA-regulated bone remodeling, immune signaling, experimental design, and program strategy.

• HDAC Inhibitors Repress NUT Carcinoma Programs

  2026-09-07

  Shiota and colleagues developed a dCas9-based GFP reporter screen to identify compounds that suppress NUT-driven transcription, uncovering structurally diverse HDAC inhibitors as potent repressors of the NUT carcinoma program. Panobinostat and IRBM6 reduced megadomain-associated oncogenic transcription, promoted differentiation, and constrained tumor growth, providing a mechanistic rationale for combining chromatin-directed therapies.

• TNF-alpha Recombinant Murine Protein Workflow

  2026-09-05

  Build reproducible apoptosis and inflammation assays with a defined, trimeric murine cytokine rather than relying on poorly characterized conditioned media. This workflow uses TNF-alpha as a receptor-initiated benchmark alongside RNA Pol II degradation studies, helping separate inflammatory signaling from transcription-independent cell death.

• Luminescent ATP Cell Viability Assay Kit I

  2026-09-04

  This scenario-based guide explains how Luminescent ATP Cell Viability Assay Kit I (SKU K2041) supports sensitive cell viability measurement, cytotoxicity testing, and proliferation studies. It covers assay principles, experimental design, protocol parameters, interpretation limits, and practical vendor-selection considerations for reproducible laboratory workflows.

• Hoe 140: Potent Bradykinin Antagonism In Vitro

  2026-09-04

  Hock and colleagues characterized Hoe 140 as a structurally distinctive, highly potent bradykinin antagonist using receptor-binding, isolated-organ, and endothelial-cell assays. The study established a major potency advance over an earlier peptide antagonist while also showing inhibition of bradykinin-dependent vascular signaling, providing a foundation for later bradykinin-pathway pharmacology.

• Amikacin Sulfate: From Mechanism to Translation

  2026-09-03

  Amikacin Sulfate is more than a conventional aminoglycoside benchmark. Its value in non-tuberculous mycobacterial research lies in connecting 30S ribosomal targeting with intracellular exposure, granulomatous tissue distribution, and delivery-led improvements in therapeutic index. This article outlines a translational framework for validating Amikacin across cellular, animal, and next-generation formulation studies.

• Gastrodin, AT1 Signaling, and Reactive Astrocytes

  2026-09-03

  A 2024 European Journal of Neuroscience study used a microglia-conditioned medium model to show that gastrodin reshapes renin–angiotensin system, SIRT3, inflammatory, and neurotrophic responses in reactive astrocytes. Pharmacological AT1 inhibition supported a role for AT1 signaling in astrocyte phenotype regulation, while the cellular design also defines important limits for translation to brain disease models.

• S-Nitrosylation Coordinates Aluminum Resistance

  2026-09-02

  A 2026 Molecular Plant study identifies nitric oxide-dependent S-nitrosylation as a mechanism that differentially regulates STOP1 and STAR1 in Arabidopsis. The findings connect STOP1-driven external aluminum exclusion with STAR1/ALS3-mediated internal sequestration and provide a framework for testing redox-sensitive cysteine regulation using reversible thiol labeling.

• Amikacin Sulfate: From Intracellular Killing to Delivery

  2026-09-02

  Amikacin Sulfate is more than a conventional aminoglycoside assay reagent: it is a translational probe for understanding how antibacterial activity, intracellular exposure, tissue targeting, and microbiome-aware discovery intersect. This article outlines a practical framework for moving from 30S ribosome mechanism to reproducible NTM models and delivery strategies.

• FUS–SMN Phase Separation in Neuronal Granules

  2026-09-01

  Wang and Li show that asymmetric arginine dimethylation enables FUS to engage oligomeric SMN through multivalent Tudor-domain interactions, promoting phase separation and neuronal granule formation. Their rescue experiments connect this molecular mechanism to axonal mRNA distribution, axon growth, and neuronal function, while highlighting SMN valency as a disease-relevant variable in spinal muscular atrophy.

• EPZ-6438: An Assay-First EZH2 Inhibitor Guide

  2026-09-01

  Explore EPZ-6438 as an EZH2 inhibitor through an assay-first lens that connects PRC2 biology, H3K27me3 pharmacodynamics, and HPV-associated cervical cancer research. Learn how to separate target engagement from downstream cytotoxicity and design more interpretable experiments.

• Ionophore Toxicity in Animals: Mechanisms and Evidence

  2026-08-31

  Ekinci, Chłodowska, and Olejnik integrate clinical observations with molecular toxicology to explain why polyether ionophores can damage myocardial and skeletal muscle in animals. The review’s main practical contribution is a framework linking dose, species, age, cation dysregulation, mitochondrial dysfunction, and tiamulin–ionophore interactions, while identifying important gaps for safer veterinary use and drug development.

• Pseudo-UTP Workflow for Stable mRNA Synthesis

  2026-08-31

  Build a controlled in vitro transcription workflow with Pseudo-UTP to test RNA stability enhancement, translation, and immune-response tradeoffs. The guide pairs nucleotide substitution with UTR optimization, using the TMSB10 reference study to design more informative mRNA vaccine development assays.

7998 records 1/534 page Next 12345 下5页 Last page